Corporate News

FarmaMondo is pleased to announce the launch of its brand new website! After months of hard work and dedication, we are delighted to officially announce the launch on February 12, 2019. The new site launch is available and the URL is www.farmamondo.com The updated site includes changes to...

FarmaMondo celebrates the recent successful establishment of its subsidiary in Copenhagen covering all 5 Nordic countries representing more than 27 million people. The Nordic expansion comes as a follow up to the successful operations established in Russia since 2015 covering 12 CIS countries. FarmaMondo continues...

Read the full interview, appeared on the magazine Healthcare and Life Sciences Review with our CEO, Mr. Jaron Spigel, regarding the uniqueness of FarmaMondo business model. With two billion people globally – predominantly in low and middle-income countries – having little or no access to medicine, a select group...

FarmaMondo is delighted to announce further expansion of its Russian operations. As of July 1st 2017 FarmaMondo Representative Office (Moscow, Russia) provides full service coverage to all Commonwealth Independent States (CIS) region. The enlarged Representative Office is a part of FarmaMondo’s global strategy of putting in place localized solution through physical...

On December 24th 2015 Farmamondo approves Normokineztine in Russian Federation for Huntington disease patients. The product, license to FarmaMondo from AOP Orphan, has been approved as the sole indicated therapy currently available for Russian patients suffering from the indicated disease. Farmamondo will launch the product in H1 2016 through...

Farmamondo and AOP Orphan signs an exclusive registration, marketing and distribution agreement for AOP’s novel therapy Tetrabenazine indicated for Huntington disease. The agreement covers the territory of Russian federation and is valid for 5 years with relevant milestones. Farmamondo’s local affiliate will be responsible to achieve Marketing Authorization and commercially...

Farmamondo completes a rebranding campaign for its Swiss local retail unit. The Swiss retail unit, known to be the corner stone of the Farmamondo historical notion of 100 years of activity, will continue to serve local community while adapting its marketing communication and value proposition to a modern business...

FarmaMondo is delighted to announce the establishment of its Brazilian subsidiary in Sao Paolo, Brazil. The subsidiary will facilitate the company’s vision and strategies in the Brazilian market and will leverage the company global capabilities to make certain, yet to be approved, therapies available to local patients through legal...